Bacteria do not live anchoretic; rather they are constantly in touch with their eukaryotic hosts and with other bacteria sharing their habitat. Therefore, bacteria have evolved sophisticated proteinaceous weapons. To harm other bacteria, they produce antibacterial effector proteins, which they either release into the environment or export via direct intercellular contact. Contact-dependent killing is mediated by two specialized secretion systems, the type V and VI secretion system, whereas contact-independent processes hijack other transport mechanisms. Regardless of the transport system, cells co-express immunity proteins to protect themselves from suicide and fratricide. In general, effector protein activities and secretion mechanisms differ between Gram-positive and Gram-negative bacteria and evidence is emerging that different effector/immunity systems act synergistically and thus extend the bacterial armory.
Introduction
Bacteria produce a multitude of effector proteins which they either export into their environment or directly into other cells. These effector molecules are targeted against eukaryotic host cells where they promote pathogenicity as virulence factors (reviewed in [1] ). Additionally, effector proteins are also used to compete with or even to gain advantage over other species during bacterial warfare within the microbiome. In the latter case, cells co-produce immunity proteins to protect themselves from suicide or fratricide. Export of effector proteins is accomplished by secretion systems (SSs) that are classified according to the transported effector molecules, their targets as well as the producing cell type (Gram-negative or Gram-positive) (reviewed in [2] [3] [4] ). The general secretion (Sec) and the two-arginine translocation (Tat) pathways and the type IV secretion system (T4SS) are found in both bacterial cell types. In contrast, the T1SS, T2SS, T3SS, T5SS, and the recently discovered T6SS have only been identified in the genome of Gram-negative bacteria, whereas the T7SS has been exclusively found in Gram-positive Mycobacteria. Depending on the secretion system, the effector proteins are either exported into the environment (T1SS, T2SS, T7SS) or are directly transported into the target cell upon physical contact (T3SS, T4SS, T5SS, T6SS). Bacteria have evolved several different secretion systems but only three (T5SS, T6SS, T7SS) have been reported to be used in bacterial growth competition. The other secretion systems have been reported to exclusively target eukaryotic cells and transport virulence factors (reviewed in [2, 5] ).
This article reviews the current knowledge of antibacterial effector/immunity systems, classified into released or injected effector proteins and discusses similarities and differences between antibacterial effector/immunity systems and the well-known toxin/antitoxin systems.
Contact-independent antibacterial systems -the bacteriocins
Bacteriocins are effector proteins that are released by bacteria into their environment and are the best characterized antibacterial effector proteins to date (reviewed in [6, 7] ). They are widespread among all bacterial species and are synthesized by ribosomes together with a cognate immunity protein that protects bacteria from their own or their sibling's bacteriocins [6, 7] . In this respect, bacteriocins are different to antibiotics such as vancomycin, which are produced by non-ribosomal peptide synthetases. Bacteriocins have a narrow spectrum of activity and primarily act on closely related species. They are highly diverse in terms of their activities, amino acid sequences and three-dimensional structures [6, 7] . Similarly, archaea produce archaeocins to gain growth advantages over their rivals (reviewed in [6] ). Although archaeocins have been predicted to be a general feature of haloarchaea [8] , only eight different halophilic strains (halocins) and Sulfolobus islandicus (sulfolobicins) have been reported to express such a system [6] .
Bacteriocins produced by Gram-negative bacteria
Gram-negative bacteriocins are named after the producing bacteria followed by the suffix -cin, with colicins from Escherichia coli being the founding and most extensively investigated members (reviewed in [7] ). These bacteriocins are encoded from a single operon together with their cognate immunity protein. Whereas most operons also encode a lysis protein that induces autolysis for effector protein release (Figure 1a) , only a few bacteriocins are released by cell wall leakage. Notably, the lysis proteins are highly conserved and functionally interchangeable between different strains [7] . Gram-negative bacteriocins generally consist of three domains; a translocation (N-terminal), a receptor binding (central) and a killing domain (C-terminal). The central domain hijacks specific receptor proteins that are usually responsible for nutrient uptake (Figure 1a ). These receptors are highly diverse among bacteria leading to a narrow killing spectrum of bacteriocins [7] . Import of bacteriocins is mediated by the recipient's Ton or Tol system ( Figure 1a ) [7, 9, 10] . These systems have been reported to make use of a proton motive force for dissociation of the tightly bound immunity proteins from the effector protein [10] and also for translocation of the bacteriocins into the target cell (reviewed in [9] ). Except for colicin M, which hydrolyzes peptidoglycan precursors [11] and pesticin from Yersinia pestis, which possesses muramidase activity [12] , all other Gram-negative bacteriocins have either pore forming or nuclease activity (Figure 1a ) [7] .
Bacteriocins produced by Gram-positive bacteria
In contrast to their Gram-negative relatives, Grampositive bacteriocins have a broad killing spectrum, and some of them even target Gram-negative bacteria (reviewed in [6, 13, 14] ). Since Gram-positive bacteriocins simply diffuse through their target's cell wall, they have a very broad killing spectrum [14] . Furthermore, when compared to Gram-negative bacteriocins, they are found in large gene clusters and their production relies on specific regulatory and transport factors [13] . Thus, Gram-positive bacteria survive bacteriocin release, whereas most Gram-negative bacteria undergo autolysis for effector protein release [13, 14] . Gram-positive bacteria, particularly lactic acid bacteria, produce a plethora of different bacterocins which are either small peptides or proteins with a molecular weight of more than 30 kDa and are grouped into four major classes: The well-known lantibiotics (class I), small heat-stable peptides (class II), heat-labile proteins that kill bacteria by either lytic or non-lytic mechanisms (class III) and cyclic peptides of which the mechanism of function is still elusive [6] . However, all these bacteriocins do not belong to the classical effector/immunity systems and are often referred to as bacteriocin-like effectors, since they are either small peptides, or do not possess any enzymatic activity or lack an immunity protein when they are classical enzymes.
The exception to the rule is the ribonuclease Barnase from Bacillus amyloliquefaciens [15] . Although Barnase and its cognate immunity protein Barstar [16] were identified 50 years ago, their putative antibacterial effector/immunity function is exclusively predicted based on similarities to bacteriocins and is still hypothetical. An antibacterial activity was suggested since E. coli cells expressing Barnase inhibit the growth of other bacteria and expression of Barstar confers immunity [17] . However, no direct evidence has been reported so far that B. amyloliquefaciens harms other bacteria using Barnase and the mechanism by which Barnase enters bacteria is also still elusive.
Contact-dependent antibacterial systems
Apart from simple secretion of effector proteins into the environment, bacteria also kill others by establishing intercellular contacts. Two different contact-dependent systems have been described so far: the contact-dependent growth inhibition (CDI) and the T6SS effector/ immunity systems.
'Toxin on a stick' -contact-dependent growth inhibition
Contact dependent growth inhibition (CDI) by the E. coli EC93 isolate is evoked by the cdiBAI operon [18] . CdiA is the effector protein consisting of two domains, a large conserved N-terminal domain (NtD) and a smaller Cterminal antibacterial effector domain (CdiA-CT) responsible for dissipating the proton motive force of the targeted cell [19] . The CdiI protein provides immunity by complex formation with CdiA effector molecules which have been secreted by siblings. Secretion of CdiA relies on CdiB, which has been predicted to be a channelforming protein (Figure 1b) [18, 20] . The CdiA effector is a large protein (about 300 kDa) and was predicted to protrude from the surface by several nanometers. The Nterminal domain of CdiA binds to the outer membrane receptor BamA of the target cell [21] and thereby establishes a direct physical contact [18] . Subsequently, CdiA-CT is most likely autoproteolytically cleaved from the Nterminal domain and assimilated into the competitor cell [18] .
However, CDI systems are much more prevalent in the genome of protebacteria than previously expected. A bioinformatic search for putative effector variants revealed an entire family of CDI operons with a conserved N-terminal BamA binding domain [22 ] . The toxic CdiA-CT domain, however, shows a significant degree of polymorphism with tRNase, DNase or pore forming activities [19, 22 ] . Although these polymorphic CdiA proteins are generally conserved in their N-terminal domain, specificity for extracellular loop regions of the BamA receptor of different bacterial species is achieved Antibacterial effector/immunity systems Benz and Meinhart 3 T5SSs are composed of two components CdiA (magenta) and CdiB (green) that are exported into the periplasm of the producer cell via their Sec-system (yellow). CdiB is a b-barrel forming protein that forms a pore in the outer membrane (OM) of the producer cell and transports CdiA across the OM. CdiA is presented on the cell surface and binds to the BamA receptor (dark blue) of host cells upon direct cell-cell contact. BamA transports CdiA across the HOM into the periplasm where it is either integrated into the membrane or further transported into the host cytoplasm (HC) by a yet unknown mechanism. CidA proteins harbor nuclease activity and inhibit bacterial cell growth by degrading tRNA or DNA of the host cell. Furthermore, to prevent suicide and fratricide, the donor cells co-express CdiI immunity proteins (magenta spheres). (c) The T6SS transports effector proteins directly into competing bacterial cells. Hcp and VgrG are highly conserved among all T6SSs and homologous to the bacteriophage tip and tube components, respectively. Assembly and disassembly of the T6SS needle is driven by ATP hydrolysis performed by ClpV. Three main classes of antibacterial T6SS effector proteins have been identified, which are active on three distinct cellular compartments of the host cell: periplasm (red), lipid bilayer (orange) or the cytoplasm (blue). On the basis of these workplaces the cognate immunity proteins (spheres colored according to the corresponding effector) are also either localized in the periplasm, membrane or in the cytoplasm of the producer cell. Effector proteins that degrade the bacterial peptidoglycan scaffold show either amidase or glycoside hydrolase activity. Effector proteins with phospholipase activity lead to cell lysis by modifying the composition of the lipid bilayer. The mechanisms and targets of cytoplasmic active effector proteins are still elusive. C: cytoplasm, IM: inner membrane, P: periplasm, OM: outer membrane, ECM: extracellular milieu, HOM: host outer membrane, HP: host periplasm, HIM: host inner membrane, HC: host cytoplasm.
by sequence variations [23] . Thereby, CDI systems achieve specificity for their target cells and establish a narrow killing spectrum as observed for Gram-negative bacteriocins [20, 22 ] . Furthermore, CDI operons always contain a small ORF located downstream of the CdiA locus. These ORFs have been predicted to encode for the cognate immunity proteins. For systems where the function has been experimentally verified, it became evident that the immunity proteins are also polymorphic and do not show any cross-reactivity with other CdiA effectors [22 ,24] .
Downstream of many of these polymorphic CDI loci, potential genes of so called 'orphan' cdiA-CT/cdiI modules are found. Whereas the cdiA-CT gene is translationally silent, the cdiI ORF is expressed, but its function is still elusive. Fusion of such an orphan cdiA-CT gene to the NtD of the upstream and functional cdiA gene resulted in an active protein secreted by CdiB. Turning on such orphan cdiA-CT/cdiI genes by homologous recombination could enable bacteria to rapidly diversify their CDI systems and enable them to express a set of CdiI proteins for broad range immunity [25] .
Strikingly, CDI loci have also been identified in rearrangement hotspot (rhs) elements, which are genomic regions that facilitate recombination in E. coli [25, 26 ] . Rhs proteins have a conserved N-terminal region, which differs from the BamA receptor binding domain of CdiA proteins and a C-terminal, variable effector domain [25, 26 ]. Similar to CdiI, a cognate RhsI immunity protein is encoded from the same operon but the channel-forming CdiB is missing [25] . Notably, CDI is not restricted to Gram-negative bacteria, and homologous proteins are also found in Gram-positive species like members of the genera Bacillus, Listeria, Clostridium and Streptococcus [27] . In fact, PF04740 proteins share conserved N-terminal domains and their C-terminal domains (CtDs) are homologous to the Gram-negative CdiA-CTs. The CtDs of B. subtilis and B. cereus have been experimentally shown to harbor RNase activity [27] . Furthermore, the ORFs downstream of the PF04740 locus encode small proteins which block growth inhibition, indicative for a functional effector/immunity pair. Similarly, the wall-associated proteins A (WapA) from various B. subtilis strains have variable C-terminal effector domains and an associated immunity protein WapI. In common, no ORF encoding for an orthologous channelforming CdiB protein has been identified for these Grampositive CDI-related effector/immunity systems and effector presentation at the surface must be accomplished by a different mechanism. Since the N-terminal domains of PF04740 proteins contain T7SS-specific secretion signals, export is most likely performed by this particular SS [27, 28] . In contrast, WapA proteins carry an N-terminal signal sequence responsible for cell wall binding [27] [28] [29] .
The number of putative polymorphic effector proteins has been increased even more by a recent bioinformatic study which identified a plethora of C-terminal toxic domains with homologous large NtDs [30] . The toxic activities of the C-terminal domains vary and range from nuclease, deaminase, ADP-ribosyltransferase, peptidase and phospholipase to pore-forming activity. All of these putative polymorphic effector proteins are encoded from an operon together with a small ORF that most likely encodes the cognate immunity proteins [30] . However, it remains to be shown if and how these polymorphic putative toxins are secreted and what their role in bacterial warfare is.
'Molecular syringes' -effector proteins injected by the type VI secretion system Type VI secretion systems (T6SSs) are found in the genome of approximately 25% of the different bacterial species [31, 32] . The T6SS injects a plethora of different effector proteins into target cells by an upside-down bacteriophage-like syringe (reviewed in [3, 33] ). Whereas anti-eukaryotic T6SS effector proteins and their role in pathogenesis have been extensively investigated (reviewed in [34] [35] [36] ), the functional mechanisms and the regulation of antibacterial effector proteins are just starting to be resolved.
The first antibacterial effector proteins secreted by a T6SS were found in the genome of P. aeruginosa and named Tse1-3 (type VI secretion exported 1-3) [37 ] . Tse1 and Tse3 act exclusively in the periplasm where they hydrolyze peptidoglycan and thereby provoke lysis of competing bacterial cells [38] . As with bacteriocins, carriers of an active T6SS co-express the immunity proteins Tsi1 and Tsi3 (type VI secretion immunity 1 and 3) from a common operon. Both immunity proteins harbor an N-terminal signal sequence for translocation into the periplasm to prevent fratricide [38] . In contrast, the third effector/immunity pair, Tse2 and Tsi2, is cytoplasmic localized and kills bacteria by an unknown mechanism (Table 1) [37 ,39] .
T6SS effector proteins with amidase activity
The discovery of the amidase activity of Tae1 (formerly referred as Tse1) led to the assignment of a plethora of previously hypothetical ORFs to an entire family of effector proteins that hydrolyse the muropeptide stems in the peptidoglycan scaffold [40 ] (Figure 2 ). On the basis of their cleavage specificity, these effectors were classified into four groups (type VI amidase effector Tae1-4) ( Table  1) . Structural characterization of these amidase effector proteins revealed a common N1pC/P60 peptidase core. Distinct structural differences clustering around the active site were observed, which probably reflect the different substrate specificities [41 ,42 ,43-49] . Whereas the amidase activity of these effector proteins is caused by a strictly conserved cysteine-histidine dyad in their active sites and the proteins are structurally homologous, their cognate immunity proteins are totally different and share no homology [41 ,42 ,43,46,47,49] (Figure 3 ).
T6SS effector proteins with glycoside hydrolase activity
Furthermore, the identification of the muramidase activity of Tse3 from P. aeruginosa (renamed to Tge1 PA /Tgi1 PA ) enabled the identification of three new classes of T6SS glycoside hydrolase effector (Tge) proteins and their cognate immunity proteins (Tgi) ( Table 1) [50] . These effector proteins cleave the b-1,4-glycosidic bond between MurNAc and GlcNAc in the peptidoglycan scaffold. On the basis of their sequence homology to other glycoside hydrolases, Tge1-3 were suggested to differ in their cleavage mechanism: lytic transglycosylase (Tge1), N-acetylglycosamidase (Tge2) and phage-type lysozyme (Tge3) (Figure 2 ). Crystal structures of Tge1 from P. aeruginosa [51, 52] and Tge2 from Pseudomonas putida [50] in complex with their cognate immunity proteins have revealed how different effector proteins of this family acquire related glycoside hydrolase activity and are inhibited by non-related immunity proteins.
T6SS effector proteins with phospholipase activity
Finally, antibacterial effector proteins that possess phospholipase activity were identified in P. aeruginosa, Burkholderia thailandensis and Vibrio cholerae [53, 54 ]. These enzymes modify the cell wall composition of competitors and were named Tle (type VI lipase effector) and their corresponding immunity proteins Tli (type VI lipase immunity). ORFs encoding for Tle proteins were identified in many other Gram-negative bacteria. On the basis of sequence homology and their phospholipase A 1 -like, A 2 -like and D-like activities, these proteins were grouped into 5 different families, Tle1-5 (Table 1 ) [53, 54 ] . Notably, T6SS effector lipases harboring both antibacterial and anti-eukaryotic killing activities were reported, suggesting that they play an important role in bacterial pathogenicity [53, 55] .
T6SS scaffold proteins with antibacterial activity
T6SSs not only secrete effector proteins, but also some of their structural components have killing potential (Table  1) [53, 56 ] . Variations of the VgrG (valine-glycine repeat G) protein which is functionally related to the bacteriophage spike proteins (reviewed in [3] ), were reported to be secreted and to harbor killing activity. For instance, the 'evolved' VgrG-3 VC from V. cholera contains a Cterminal, lysozyme-like peptidoglycan binding domain and hydrolyzes the cell wall of Gram-negative competitors [53, 56 ]. VgrG-3 VC was suggested to be part of a functional effector immunity pair, since the downstream gene product encodes the cognate immunity protein TsaB [53, 56 ] . Since VgrG proteins form the tip of the T6SS syringe, other functions apart from solely inducing cell lysis are also conceivable. For instance, peptidoglycan Antibacterial effector/immunity systems Benz and Meinhart 5 degradation by VgrG-3 could facilitate penetration through the producer's cell envelope during needle formation [56 ] . 'Evolved' VgrG proteins could act as an advance guard by increasing the cell wall permeability of other bacteria and thereby facilitating injection or infusion of other effector proteins. A stealthy penetration of effector proteins into the competitor cell by VgrG proteins is further supported by physical interaction between VgrG-3 VC and the phospholipase effector Tle2 VC [53] . Finally, it remains to be shown whether cell wall hydrolysis activity of 'evolved' VgrG proteins is also used to attack Gram-positive bacteria.
T66S effector proteins are commonly used antibacterial weapons
Evidence is emerging that the T6SS effector/immunity proteins characterized so far are just the tip of the iceberg and that the bacterial armory is more extensive and complex than previously thought. For instance, different Acinetobacter baumannii strains contain conserved T6SS loci [57, 58] , however, not all of them exhibit killing activity towards other bacteria under the conditions tested [58] . This suggests that effector protein secretion is strictly regulated and not activated by common mechanisms, even not in closely related species. Moreover, effector proteins might even not be secreted under laboratory conditions or are only activated under certain conditions. This hypothesis is further supported by the failure to detect any T6SS activity in re-cultured pandemic V. cholera strains under laboratory conditions [59] . Additionally, antibacterial T6SS activity was identified in various bacteria but no effector proteins could be assigned yet [57, 60 ] . In other studies, putative effector proteins could be identified, but their killing activity and cellular targets are still elusive [37 ,39,61 ] .
Effector/immunity systems and other toxins -an interdisciplinary assassination team?
Effector/immunity and type II toxin/antitoxin (TA) systems are often spuriously mixed, as both induce cell death in bacteria and their genomic organization in bicistronic operons is related. However, there is a fundamental, functional difference between the two systems. Effector proteins are released and serve to attack competitors and the stable immunity proteins provide 
Peptidoglycan cleavage specificity of the different amidase and glycoside hydrolase effector protein families. Cleavage specificity of Tae1-4 on pentapeptide (left panel) and tetrapeptide (right panel) stems of bacterial peptidoglycan is illustrated according to [38, 40 ] . Effector proteins that belong to the Tae2 and Tae3 family hydrolyze the cross-link between mDAP and D-Ala in tetrapeptides as well as in pentapeptides. In contrast, Tae1 and Tae4 effector proteins degrade the peptidoglycan by hydrolyzing the amide bond formed between g-D-Glu and mDAP. Whereas, Tae1 effector proteins, including the founding member Tse1 from Pseudomonas aeruginosa, specifically cleave the donor stem of cross-linked tetrapeptides, Tae4 effector proteins exclusively degrade acceptor stems of cross-linked as well as non-crosslinked tetrapeptides. Furthermore, pentapeptides can also be degraded by Tae4 family members but with a poor turnover rate. Additionally, bacteria express effector proteins with glycoside hydrolase activity and degrade the peptidoglycan scaffold by cleaving the bond between the sugar moieties. Classification of these Tge proteins is according to [50] . long-term protection against siblings [39] . In contrast, toxin proteins rest inside the cell and the unstable antitoxin provides only temporary protection and thus toxin/ antitoxin systems induce bacterial suicide upon activation (reviewed in [62] ).
But evidence is emerging that both systems have common origins and/or overlapping functions and a strict separation is not always possible. For instance, both systems are often found within mobile genetic elements, pathogenicity islands and transposon-like regions (reviewed in [7,22 ,63,64] ). It remains to be shown whether TA toxins are translocated in addition to effector proteins by SSs and directly used as weapons against competitors. Such a hijack of the T6SS by non-related T6SS toxins has been shown, for instance for the Rhs proteins of Serratia marcescens [61 ] and Dickeya dadantii [25, 26 ] . As Rhs loci do not encode for any CdiB homologue nor do Rhs proteins harbor any leader sequence for CdiB-dependent transport they need to hijack other SSs [25] . Transport via the T6SS is rather likely, since Rhs Antibacterial effector/immunity systems Benz and Meinhart 7 loci are often found next to vgrG genes [25] and Rhsmediated bacterial growth inhibition relies on VgrG proteins [26 ] . However, this transport might not be accomplished through the injection needle, since the diameter of the Hcp tube (40 Å ) [65] seems to be too narrow for Rhs proteins. Most likely the conserved PAAR (proline-alanine-alanine-arginine) repeat domain of Rhs proteins localizes to the VgrG tip before assembly of the tube [66 ] . Notably, many uncharacterized PAAR-repeat proteins carry polymorphic C-terminal extensions with enzymatic functions like nuclease, peptidase or lipase activities and might fulfill similar functions [26 ,66 ] .
Conclusion
Effector proteins involved in bacterial competition are a highly polymorphic group of bacterial toxins that apparently form an interdisciplinary and synergistic team to kill competitors during warfare. It seems that just the tip of the iceberg of this arsenal has been discovered and many questions need to be answered before we fully understand bacterial competition and communication and its involvement in pathogenicity.
